Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112781) titled 'Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer' on Aug. 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Branch Office of "Hadassah Medical Ltd"

Condition: Prostate Cancer

Intervention: Radiation: Single Dose Radiotherapy

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: July 24, 2024

Target Sample Size: 30

Countries of Recruitment: Russian Federation

To know more, visit https://clinicaltrials.gov/ct2/...